BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36794499)

  • 1. ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis.
    Basso-Valentina F; Donada A; Manchev VT; Lisetto M; Balayn N; Martin JE; Muller D; Oyarzun CPM; Duparc H; Arkoun B; Cumin A; Faivre L; Droin N; Biunno I; Pecci A; Balduini A; Debili N; Antony-Debré I; Marty C; Vainchenker W; Plo I; Favier R; Raslova H
    Haematologica; 2023 Aug; 108(8):2130-2145. PubMed ID: 36794499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation.
    Bluteau D; Balduini A; Balayn N; Currao M; Nurden P; Deswarte C; Leverger G; Noris P; Perrotta S; Solary E; Vainchenker W; Debili N; Favier R; Raslova H
    J Clin Invest; 2014 Feb; 124(2):580-91. PubMed ID: 24430186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5'UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia.
    Marconi C; Canobbio I; Bozzi V; Pippucci T; Simonetti G; Melazzini F; Angori S; Martinelli G; Saglio G; Torti M; Pastan I; Seri M; Pecci A
    J Hematol Oncol; 2017 Jan; 10(1):18. PubMed ID: 28100250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and natural history of variants in the
    Vyas H; Alcheikh A; Lowe G; Stevenson WS; Morgan NV; Rabbolini DJ
    Platelets; 2022 Nov; 33(8):1107-1112. PubMed ID: 35587581
    [No Abstract]   [Full Text] [Related]  

  • 5. ANKRD26-Related Thrombocytopenia and Predisposition to Myeloid Neoplasms.
    Sullivan MJ; Palmer EL; Botero JP
    Curr Hematol Malig Rep; 2022 Oct; 17(5):105-112. PubMed ID: 35751752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited Thrombocytopenia Caused by Germline
    Kewan T; Noss R; Godley LA; Rogers HJ; Carraway HE
    J Investig Med High Impact Case Rep; 2020; 8():2324709620938941. PubMed ID: 32618208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between mutations in the 5' UTR of ANKRD26 gene and inherited thrombocytopenia with predisposition to myeloid malignancies. An Egyptian study.
    Zidan NI; AbdElmonem DM; Elsheikh HM; Metwally EA; Mokhtar WA; Osman GM
    Platelets; 2021 Jul; 32(5):642-650. PubMed ID: 32659145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA binding protein 2 mediated ankyrin repeat domain containing 26 high expression in myeloid-derived cell lines.
    Jiang YZ; Hu LY; Chen MS; Wang XJ; Tan CN; Xue PP; Yu T; He XY; Xiang LX; Xiao YN; Li XL; Ran Q; Li ZJ; Chen L
    World J Stem Cells; 2024 May; 16(5):538-550. PubMed ID: 38817334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
    Drexler HG; Quentmeier H
    Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of the human induced pluripotent stem cell line (SHAMUi001-A) carrying the heterozygous c.-128G>T mutation in the 5'-UTR of the ANKRD26 gene.
    Tan C; Dai L; Yang W; Li F; Wang L; Xiao Y; Wang X; Zhang Y; Wang Y; Zeng C; Xiang Z; Zhang X; Zhang W; Ran Q; Chen M; Li Z; Chen L
    Stem Cell Res; 2020 Oct; 48():102002. PubMed ID: 32979630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines.
    Drexler HG; Quentmeier H
    Hum Cell; 1996 Dec; 9(4):309-16. PubMed ID: 9183663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
    Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
    Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation.
    Goncalves F; Lacout C; Villeval JL; Wendling F; Vainchenker W; Dumenil D
    Blood; 1997 May; 89(10):3544-53. PubMed ID: 9160659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of thrombopoietin and thrombopoietin receptor MPL in human leukemia-lymphoma and solid tumor cell lines.
    Graf G; Dehmel U; Drexler HG
    Leuk Res; 1996 Oct; 20(10):831-8. PubMed ID: 8960108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families.
    Noris P; Perrotta S; Seri M; Pecci A; Gnan C; Loffredo G; Pujol-Moix N; Zecca M; Scognamiglio F; De Rocco D; Punzo F; Melazzini F; Scianguetta S; Casale M; Marconi C; Pippucci T; Amendola G; Notarangelo LD; Klersy C; Civaschi E; Balduini CL; Savoia A
    Blood; 2011 Jun; 117(24):6673-80. PubMed ID: 21467542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel RUNX1 mutation with ANKRD26 dysregulation is related to thrombocytopenia in a sporadic form of myelodysplastic syndrome.
    Ferrari S; Regazzo D; Omenetto E; Scaroni C; Semenzato G; Fabris F; Vianello F
    Aging Clin Exp Res; 2021 Jul; 33(7):1987-1992. PubMed ID: 32944898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the 5' UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2.
    Pippucci T; Savoia A; Perrotta S; Pujol-Moix N; Noris P; Castegnaro G; Pecci A; Gnan C; Punzo F; Marconi C; Gherardi S; Loffredo G; De Rocco D; Scianguetta S; Barozzi S; Magini P; Bozzi V; Dezzani L; Di Stazio M; Ferraro M; Perini G; Seri M; Balduini CL
    Am J Hum Genet; 2011 Jan; 88(1):115-20. PubMed ID: 21211618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of GATA-2 inhibits erythroid and promotes megakaryocyte differentiation.
    Ikonomi P; Rivera CE; Riordan M; Washington G; Schechter AN; Noguchi CT
    Exp Hematol; 2000 Dec; 28(12):1423-31. PubMed ID: 11146164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine receptor splice variants in hematologic diseases.
    Wang B; Mehta H
    Cytokine; 2020 Mar; 127():154919. PubMed ID: 31816579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pivotal role of granulocyte colony-stimulating factor in the development of progenitors in the common myeloid pathway.
    Richards MK; Liu F; Iwasaki H; Akashi K; Link DC
    Blood; 2003 Nov; 102(10):3562-8. PubMed ID: 12893769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.